OECD Forum Series 2022: Closing the Cancer Gap: Towards Better Screening and Treatment


Amadou Diarra

Global Policy, Advocacy & Gov’t Affairs, Bristol Myers Squibb

Senior Vice President


Amadou leads an integrated organization focused on external policy environment dynamics, innovation and patient access, working with key stakeholders including policymakers, patient support organizations, health care professionals and industry associations. Amadou joined BMS in 1991 holding positions of increasing responsibility. From 1999 to 2002 he led Secure the Future (landmark philanthropic program) before becoming General Manager in Indonesia (2002), Turkey (2005), Ireland & Nordics (2008), VP-Access Europe and then VP-General Manager-UK & Ireland (2010) with responsibilities including European Works Council Chair, Association of the British Pharmaceutical Industry Board Member, also being Health Technology Assessment Task Force and Reputation Strategy Group Chair. Amadou holds a Doctorate in Pharmacy, University of Tours (France), a MBA from École Supérieure de Commerce de Tours and completed the General Management Program (INSEAD). Amadou represents Bristol Myers Squibb as an American Associate of the Science & Technology in Society Forum (STSF), Member and former 4 years-term Chair of the Pharmaceutical Research and Manufacturers of America (PhRMA) International Section Executive Committee (ISEC), Council Chair of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) where he also chaired the Value & Access Committee. At Bristol Myers Squibb Amadou is a member of the Global Leadership Team as well as the Global Diversity & Inclusion Council and Sustainability Council. He is also Executive Sponsor for the Corporate Affairs Diversity & Inclusion Working Group.